NCT01462604View on ClinicalTrials.gov

Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

November 23, 2011

Primary Completion Date

January 1, 2013

Study Completion Date

January 24, 2013

Conditions
Cancer
Interventions
OTHER

non-drug intervention educational programme

educational programme

Trial Locations (7)

54600

GSK Investigational Site, Lahore

258500

GSK Investigational Site, Singapore

308433

GSK Investigational Site, Singapore

Unknown

GSK Investigational Site, Pokfulam

GSK Investigational Site, Shatin

GSK Investigational Site, Karachi

120-752

GSK Investigational Site, Seoul

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01462604 - Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter